Asklepios Kliniken Hamburg GmbH

The medical center is at the forefront of research in hematologic oncology, focusing on innovative treatments for conditions such as mantle cell lymphoma and multiple myeloma. The center's trials explore the efficacy of novel drug combinations and stem cell transplantation techniques.

• Autologous Transplantation in Mantle Cell Lymphoma
• Elotuzumab and Carfilzomib in Multiple Myeloma
• Isatuximab in High-Risk Multiple Myeloma

These studies aim to improve failure-free survival and progression-free survival in patients, setting new standards in treatment protocols.

Specializing in non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), the center conducts pivotal trials to assess the safety and efficacy of targeted therapies and immunotherapies. These studies are crucial for advancing treatment options for lung cancer patients.

• Dato-DXd in Advanced NSCLC
• Zipalertinib for EGFR Mutations
• JDQ443 in KRAS G12C-mutated NSCLC

Research efforts focus on improving progression-free survival and overall survival, offering hope for better patient outcomes.

The center is a leader in gastrointestinal oncology, with a strong emphasis on developing new treatments for pancreatic cancer and colorectal cancer. Innovative trials are underway to evaluate the effectiveness of combination therapies and novel agents.

• Tumor Treating Fields in Pancreatic Cancer
• Amivantamab in Colorectal Cancer
• Pelareorep in Advanced GI Tumors

These studies aim to enhance disease control rates and overall survival, contributing to significant advancements in the field.

Focusing on renal cell carcinoma and urothelial carcinoma, the center's research explores the potential of immunotherapy and targeted treatments. These efforts are crucial for improving therapeutic outcomes in genitourinary cancers.

• Pembrolizumab in Renal Cell Carcinoma
• Nivolumab in Urothelial Cancer
• V940 in High-Risk RCC

Research initiatives aim to enhance disease-free survival and overall survival, offering new hope for patients.

The center is pioneering research in cardiovascular diseases, with a focus on innovative treatments for conditions such as hypertension and calcific aortic valve stenosis. These studies are essential for developing new therapeutic strategies.

• Renal Denervation in Hypertension
• Pelacarsen in Aortic Valve Stenosis

Research efforts are directed towards improving patient outcomes and advancing the understanding of cardiovascular conditions.